Effect of Continuous Positive Airway Pressure on glycated hemoglobin in patients with type 2 diabetes and Obstructive Sleep Apnea

Effect of Continuous Positive Airway Pressure on glycated hemoglobin in patients with type 2 diabetes and Obstructive Sleep Apnea

Obstructive sleep apnea (OSA) is a risk factor for type 2 diabetes that adversely impacts glycemic control. However, there is little evidence about the effect of continuous positive airway pressure (CPAP) on glycemic control in patients with diabetes. Assess the effect of CPAP on glycated hemoglobin...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Tunisie Medicale 2019-12, Vol.97 (12), p.1345-1352
Hauptverfasser: Gharsalli, Houda, Oueslati, Ibtissem, Sahnoun, Imen, Neffati, Othmen, Ghrairi, Najla, Maalej, Sonia, Douik El Gharbi, Leila
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1352
container_issue 12
container_start_page 1345
container_title Tunisie Medicale
container_volume 97
creator Gharsalli, Houda
Oueslati, Ibtissem
Sahnoun, Imen
Neffati, Othmen
Ghrairi, Najla
Maalej, Sonia
Douik El Gharbi, Leila
description Obstructive sleep apnea (OSA) is a risk factor for type 2 diabetes that adversely impacts glycemic control. However, there is little evidence about the effect of continuous positive airway pressure (CPAP) on glycemic control in patients with diabetes. Assess the effect of CPAP on glycated hemoglobin (HbA1c) levels in patients with type 2 diabetes and OSA. it was a prospective study including type 2 diabetic patients with OSA and a CPAP therapy indication. All participants had HbA1c measurement at baseline (T0) and 2 months after the onset of CPAP (T1) with a compliance ≥ 4 hours / night. Patients who changed anti-diabetic treatment during follow-up were excluded. The HbA1c level goal was ≤ 7%. Thirty patients were included (4 men and 26 women) with a mean age of 61.3 ± 8.8 years. The mean diabetes duration was 5.8 ± 3.7 years. Twenty-four patients had poorly controlled diabetes. Associated comorbidities were dominated by hypertension (n=22) and obesity (n=22). The mean apnea hypopnea index was 38.0 ± 12.7/ hour. Two months after the CPAP use, a significant decrease of 1.1 ± 0.8 % in the mean HbA1c level was observed (HbA1c: T0= 8.9 ± 1.5 % vs T1=7.8 ± 1.1 %; p 9%.
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_2377678545</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2377678545</sourcerecordid><originalsourceid>FETCH-LOGICAL-p563-b081de32f87bab50ba8b0b5074d89d5664d2335eeb7df26bad62d3ae103fa5783</originalsourceid><addsrcrecordid>eNo1kD1rwzAYhD20NCHNXyjv2MUgWZbljCGkHxBIoNmNZL1OVGxJteQGj_3nNU16HNzycHB3l8wJyWmaU0ZnyTKETzKpIHTF6UMyYxkVrCRsnvxsmwbrCK6BjbPR2MENAQ4umGi-Edamv8gRDj2GMPQIzsKpHWsZUcMZO3dqnTIWJnsZDdoY4GLiGeLoETLQRiqMGEBaDXsVYj_Uf70fLaKHtbcoH5P7RrYBl7dcJMeX7XHzlu72r--b9S71vGCpIiXVyLKmFEoqTpQsFZlS5LpcaV4Uuc4Y44hK6CYrlNRFpplESlgjuSjZInm-1vrefQ0YYtWZUGPbSovT5CpjQhSi5Dmf0KcbOqgOdeV708l-rP5fY797mWqT</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2377678545</pqid></control><display><type>article</type><title>Effect of Continuous Positive Airway Pressure on glycated hemoglobin in patients with type 2 diabetes and Obstructive Sleep Apnea</title><source>Alma/SFX Local Collection</source><source>EZB Electronic Journals Library</source><creator>Gharsalli, Houda ; Oueslati, Ibtissem ; Sahnoun, Imen ; Neffati, Othmen ; Ghrairi, Najla ; Maalej, Sonia ; Douik El Gharbi, Leila</creator><creatorcontrib>Gharsalli, Houda ; Oueslati, Ibtissem ; Sahnoun, Imen ; Neffati, Othmen ; Ghrairi, Najla ; Maalej, Sonia ; Douik El Gharbi, Leila</creatorcontrib><description>Obstructive sleep apnea (OSA) is a risk factor for type 2 diabetes that adversely impacts glycemic control. However, there is little evidence about the effect of continuous positive airway pressure (CPAP) on glycemic control in patients with diabetes. Assess the effect of CPAP on glycated hemoglobin (HbA1c) levels in patients with type 2 diabetes and OSA. it was a prospective study including type 2 diabetic patients with OSA and a CPAP therapy indication. All participants had HbA1c measurement at baseline (T0) and 2 months after the onset of CPAP (T1) with a compliance ≥ 4 hours / night. Patients who changed anti-diabetic treatment during follow-up were excluded. The HbA1c level goal was ≤ 7%. Thirty patients were included (4 men and 26 women) with a mean age of 61.3 ± 8.8 years. The mean diabetes duration was 5.8 ± 3.7 years. Twenty-four patients had poorly controlled diabetes. Associated comorbidities were dominated by hypertension (n=22) and obesity (n=22). The mean apnea hypopnea index was 38.0 ± 12.7/ hour. Two months after the CPAP use, a significant decrease of 1.1 ± 0.8 % in the mean HbA1c level was observed (HbA1c: T0= 8.9 ± 1.5 % vs T1=7.8 ± 1.1 %; p&lt;0.001). This rate was significantly correlated with the body weight (r = 0.51, p = 0.003), the body mass index (r = 0.42, p = 0.02) and the HbA1c level at baseline (r = 0, 76, p &lt;0.001). The only factor associated with glycemic control improvement was an initial HbA1c level &gt; 9% (Odds Ratio = 8.3, p = 0.04). CPAP therapy improved diabetes control in type 2 diabetic patients with OSA, in particular in those with an initial HbA1c&gt; 9%.</description><identifier>ISSN: 0041-4131</identifier><identifier>PMID: 32173803</identifier><language>eng</language><publisher>Tunisia</publisher><ispartof>Tunisie Medicale, 2019-12, Vol.97 (12), p.1345-1352</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32173803$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gharsalli, Houda</creatorcontrib><creatorcontrib>Oueslati, Ibtissem</creatorcontrib><creatorcontrib>Sahnoun, Imen</creatorcontrib><creatorcontrib>Neffati, Othmen</creatorcontrib><creatorcontrib>Ghrairi, Najla</creatorcontrib><creatorcontrib>Maalej, Sonia</creatorcontrib><creatorcontrib>Douik El Gharbi, Leila</creatorcontrib><title>Effect of Continuous Positive Airway Pressure on glycated hemoglobin in patients with type 2 diabetes and Obstructive Sleep Apnea</title><title>Tunisie Medicale</title><addtitle>Tunis Med</addtitle><description>Obstructive sleep apnea (OSA) is a risk factor for type 2 diabetes that adversely impacts glycemic control. However, there is little evidence about the effect of continuous positive airway pressure (CPAP) on glycemic control in patients with diabetes. Assess the effect of CPAP on glycated hemoglobin (HbA1c) levels in patients with type 2 diabetes and OSA. it was a prospective study including type 2 diabetic patients with OSA and a CPAP therapy indication. All participants had HbA1c measurement at baseline (T0) and 2 months after the onset of CPAP (T1) with a compliance ≥ 4 hours / night. Patients who changed anti-diabetic treatment during follow-up were excluded. The HbA1c level goal was ≤ 7%. Thirty patients were included (4 men and 26 women) with a mean age of 61.3 ± 8.8 years. The mean diabetes duration was 5.8 ± 3.7 years. Twenty-four patients had poorly controlled diabetes. Associated comorbidities were dominated by hypertension (n=22) and obesity (n=22). The mean apnea hypopnea index was 38.0 ± 12.7/ hour. Two months after the CPAP use, a significant decrease of 1.1 ± 0.8 % in the mean HbA1c level was observed (HbA1c: T0= 8.9 ± 1.5 % vs T1=7.8 ± 1.1 %; p&lt;0.001). This rate was significantly correlated with the body weight (r = 0.51, p = 0.003), the body mass index (r = 0.42, p = 0.02) and the HbA1c level at baseline (r = 0, 76, p &lt;0.001). The only factor associated with glycemic control improvement was an initial HbA1c level &gt; 9% (Odds Ratio = 8.3, p = 0.04). CPAP therapy improved diabetes control in type 2 diabetic patients with OSA, in particular in those with an initial HbA1c&gt; 9%.</description><issn>0041-4131</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNo1kD1rwzAYhD20NCHNXyjv2MUgWZbljCGkHxBIoNmNZL1OVGxJteQGj_3nNU16HNzycHB3l8wJyWmaU0ZnyTKETzKpIHTF6UMyYxkVrCRsnvxsmwbrCK6BjbPR2MENAQ4umGi-Edamv8gRDj2GMPQIzsKpHWsZUcMZO3dqnTIWJnsZDdoY4GLiGeLoETLQRiqMGEBaDXsVYj_Uf70fLaKHtbcoH5P7RrYBl7dcJMeX7XHzlu72r--b9S71vGCpIiXVyLKmFEoqTpQsFZlS5LpcaV4Uuc4Y44hK6CYrlNRFpplESlgjuSjZInm-1vrefQ0YYtWZUGPbSovT5CpjQhSi5Dmf0KcbOqgOdeV708l-rP5fY797mWqT</recordid><startdate>201912</startdate><enddate>201912</enddate><creator>Gharsalli, Houda</creator><creator>Oueslati, Ibtissem</creator><creator>Sahnoun, Imen</creator><creator>Neffati, Othmen</creator><creator>Ghrairi, Najla</creator><creator>Maalej, Sonia</creator><creator>Douik El Gharbi, Leila</creator><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>201912</creationdate><title>Effect of Continuous Positive Airway Pressure on glycated hemoglobin in patients with type 2 diabetes and Obstructive Sleep Apnea</title><author>Gharsalli, Houda ; Oueslati, Ibtissem ; Sahnoun, Imen ; Neffati, Othmen ; Ghrairi, Najla ; Maalej, Sonia ; Douik El Gharbi, Leila</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p563-b081de32f87bab50ba8b0b5074d89d5664d2335eeb7df26bad62d3ae103fa5783</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gharsalli, Houda</creatorcontrib><creatorcontrib>Oueslati, Ibtissem</creatorcontrib><creatorcontrib>Sahnoun, Imen</creatorcontrib><creatorcontrib>Neffati, Othmen</creatorcontrib><creatorcontrib>Ghrairi, Najla</creatorcontrib><creatorcontrib>Maalej, Sonia</creatorcontrib><creatorcontrib>Douik El Gharbi, Leila</creatorcontrib><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Tunisie Medicale</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gharsalli, Houda</au><au>Oueslati, Ibtissem</au><au>Sahnoun, Imen</au><au>Neffati, Othmen</au><au>Ghrairi, Najla</au><au>Maalej, Sonia</au><au>Douik El Gharbi, Leila</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of Continuous Positive Airway Pressure on glycated hemoglobin in patients with type 2 diabetes and Obstructive Sleep Apnea</atitle><jtitle>Tunisie Medicale</jtitle><addtitle>Tunis Med</addtitle><date>2019-12</date><risdate>2019</risdate><volume>97</volume><issue>12</issue><spage>1345</spage><epage>1352</epage><pages>1345-1352</pages><issn>0041-4131</issn><abstract>Obstructive sleep apnea (OSA) is a risk factor for type 2 diabetes that adversely impacts glycemic control. However, there is little evidence about the effect of continuous positive airway pressure (CPAP) on glycemic control in patients with diabetes. Assess the effect of CPAP on glycated hemoglobin (HbA1c) levels in patients with type 2 diabetes and OSA. it was a prospective study including type 2 diabetic patients with OSA and a CPAP therapy indication. All participants had HbA1c measurement at baseline (T0) and 2 months after the onset of CPAP (T1) with a compliance ≥ 4 hours / night. Patients who changed anti-diabetic treatment during follow-up were excluded. The HbA1c level goal was ≤ 7%. Thirty patients were included (4 men and 26 women) with a mean age of 61.3 ± 8.8 years. The mean diabetes duration was 5.8 ± 3.7 years. Twenty-four patients had poorly controlled diabetes. Associated comorbidities were dominated by hypertension (n=22) and obesity (n=22). The mean apnea hypopnea index was 38.0 ± 12.7/ hour. Two months after the CPAP use, a significant decrease of 1.1 ± 0.8 % in the mean HbA1c level was observed (HbA1c: T0= 8.9 ± 1.5 % vs T1=7.8 ± 1.1 %; p&lt;0.001). This rate was significantly correlated with the body weight (r = 0.51, p = 0.003), the body mass index (r = 0.42, p = 0.02) and the HbA1c level at baseline (r = 0, 76, p &lt;0.001). The only factor associated with glycemic control improvement was an initial HbA1c level &gt; 9% (Odds Ratio = 8.3, p = 0.04). CPAP therapy improved diabetes control in type 2 diabetic patients with OSA, in particular in those with an initial HbA1c&gt; 9%.</abstract><cop>Tunisia</cop><pmid>32173803</pmid><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0041-4131
ispartof Tunisie Medicale, 2019-12, Vol.97 (12), p.1345-1352
issn 0041-4131
language eng
recordid cdi_proquest_miscellaneous_2377678545
source Alma/SFX Local Collection; EZB Electronic Journals Library
title Effect of Continuous Positive Airway Pressure on glycated hemoglobin in patients with type 2 diabetes and Obstructive Sleep Apnea
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T17%3A49%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20Continuous%20Positive%20Airway%20Pressure%20on%20glycated%20hemoglobin%20in%20patients%20with%20type%202%20diabetes%20and%20Obstructive%20Sleep%20Apnea&rft.jtitle=Tunisie%20Medicale&rft.au=Gharsalli,%20Houda&rft.date=2019-12&rft.volume=97&rft.issue=12&rft.spage=1345&rft.epage=1352&rft.pages=1345-1352&rft.issn=0041-4131&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E2377678545%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2377678545&rft_id=info:pmid/32173803&rfr_iscdi=true